The global Immune thrombocytopenia market was valued at USD 2.18 billion in 2019 and is expected to reach USD 3.68 billion by the year 2027, at a CAGR of 6.7%
The global Immune thrombocytopenia market was valued at USD 2.18 billion in 2019 and is expected to reach USD 3.68 billion by the year 2027, at a CAGR of 6.7%. The global Immune thrombocytopenia market is growing at a substantial pace owing to the growing demand therapy for rare diseases such as immune thrombocytopenia, favorable government initiatives taken up by the authorities, availability of financial support for research and development. With the advent of technology, research has contributed significantly to the number of updates and development of treatment for the disorder. Researchers in emerging economies provide the untapped potential for the market to grow. Furthermore, it has highlighted the necessity of developing new therapies for this disorder; and is expected to have high demand in the near future. Market players, in collaboration with research centers, invest a handful of the amount in their R&D, which would fuels up the market growth by a large margin.
Access Free sample PDF Copy of the Report (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/3401
Previously, limited clinical and laboratory parameters were available to define and classify the disease. However, significant standardization has enabled the alignment of research studies and guidance in the management of patients suffering from disorders. For instance, In January 2020, Rigel Pharmaceuticals, Inc. announced the launch of TAVLESSE in Europe with its collaborative partner Grifols S.A. The product was launched in Germany and the United Kingdom. The European Commission in January 2020 approved it for the treatment of chronic immune thrombocytopenia in adult patients who are refractory to other treatments. A cost-effective therapeutic approach and strategies for drug development are being adopted by market players. Such advantages are expected to propel the market significantly during the forecast period. Clinical trials are now underway to learn new areas of therapeutics for the same that can improve patients’ outcomes.
For instance, in August 2019, Chi-Med Initiated a Phase I Trial of HMPL-523 in patients with immune thrombocytopenia in China. Such an initiative is proving successful for many conditions. Moreover, Pharmaceutical companies, physicians, and the public anticipate the promise of significant advancements in the near future. In the coming future, combination therapy, hormone therapy are the goal to strive for. This trend is projected to continue over the forecast period as the proportion of adults who have a chronic condition is much higher, exceeding 50% in most series. However, lack of awareness in emerging economies and insufficient research funding may hamper the market.
Further key findings from the report suggest
- The North America Immune thrombocytopenia market is anticipated to dominate the in the global market. The major driving factors for the growth of this market are rising awareness about the disease and favourable research funding scenario and government initiatives, and high medical reimbursement facilities.
- Based on product segment, corticosteroids are expected to have the largest market share among the other segments during the forecast period. This is attributed to the widespread application of corticosteroids to effectively influence healthcare outcomes. Moreover, it is most common form of treatment owing to its potential benefits.
- The market is widely driven by increasing second- and third-line therapies. Moreover, the understanding about the disorder and therapeutic has expanded greatly owing to the increased demand of therapy in the near future. For instance, in January 2020, Rigel Pharmaceuticals, Inc. announced the launch of TAVLESSE (Spleen tyrosine kinase inhibitor) in Europe with its collaborative partner Grifols S.A. The product was launched Germany and the United Kingdom.
- The immune globulin injection is expected to have significant market share during the forecast period. Over the period, the awareness about the disease and the existing treatment has risen up. The research has contributed to a number of updates in the diagnosis and treatment of the disorder which will contribute significantly to the market.
- Chronic Immune thrombocytopenia is expected to have high CAGR during the forecast period. European regional market is the prominent revenue generating source for this product segment, followed by North America, Asia-Pacific, and other regions. However, associated side effects associated with the treatment is expected to hamper the market.
- Research organizations are expected to be the largest segment for the Immune thrombocytopenia market during the forecast period. The growth is contributed to its wide application in research field. It is relatively an orphan disease whose expertise in the management of these patient is not wide spread. Therefore to develop effective, safe medications and doses, researchers would further impact the market positively.
The ongoing pandemic is significantly changing the dynamics of the pharma and healthcare sector. Various countries are facing challenges such as shortage of medicines, vaccines, healthcare devices in hospitals. This is expected to open lucrative growth opportunities for market players in the coming years.
For Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/3401
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, merger and acquisitions, collaborations, and joint ventures to gain robust footing in the market.
Top Companies Profiled in the Report:
Hoffman-L Roche, Novartis, GlaxoSmithKline, Eisai, Amgen, Grifols Biologicals Inc., Contract Pharmacal, Baxter, CSL Behring, Bristol-Myers Squibb, Roxane, and others.
Browse Full Report Description with Research Methodology, Table of Content and Infographics @ https://www.reportsanddata.com/report-detail/immune-thrombocytopenia-itp-market
Immune Thrombocytopenia Market Segmentation:
Products Outlook (Revenue, USD million; 2017-2027)
- Corticosteroids
- Intravenous Immunoglobulin (IVIG)
- Anti-D Immunoglobulin
- Spleen tyrosine kinase inhibitor
- Rho (D) immunoglobulin intravenous
- Thrombopoietin Receptor Agonists (TPO-RA)
- Romiplostim
- Eltrombopag
- General immunosuppressants
- Cyclophosphamide
- Azathioprine
- Mycophenolate
- Antibiotics
- Hormone therapy
- Splenectomy
- Others
Type Outlook (Revenue, USD million; 2017-2027)
- Acute
- Chronic
End Use Outlook (Revenue, USD million; 2017-2027)
- Hospitals and clinics
- Research Organisation
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Ask for Customize Research Report @ https://www.reportsanddata.com/request-customization-form/3401
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Press Release Available @ https://www.reportsanddata.com/press-release/global-immune-thrombocytopenia-itp-market
Explore More Industry Research by Reports and Data:
Pressure Relief Devices Market Size, Share, Trends, By Type (Static, Dynamic), By Application (Pressure Ulcers, Foot Ulcers), By End Use (Hospitals, Clinics, Long Term Care Centers) and By Region Forecast to 2030 Download PDF Brochure
Cell Culture Protein Surface Coating Market Analysis, By Coating Type (Self-Coating, Pre-Coating), By Protein Source (Animal-derived Protein, Human-derived Protein, Synthetic Protein, Plant-derived Protein), By End Use, By Region, Forecasts To 2028 Download PDF Brochure
Medical Specialty Bags Market Analysis, By Type (Ostomy Bags, CAPD Bags, Blood Bags, IV Fluids Bags, Enteral Feeding Bags, Bile Collection) By End Use (Healthcare centers, Hospitals, Home Healthcare, SurgiCenters), Forecasts To 2028 Download PDF Brochure
Teleradiology Market Size, Share and Analysis By Imaging Technique (Computed Tomography (CT), X-ray, Nuclear Imaging, Fluoroscopy, Mammography, Others), By End-Use (Hospitals, Diagnostic Centers, Ambulatory Service Centers, Others), Region- Forecasts To 2028 Download PDF Brochure
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos